Report cover image

Cardiometabolic Diseases Global Market Report 2023 Including: 1) By Type: Chronic/Congestive Heart Failure; Hypertension; Type 2 Diabetes; Obesity 2) By Treatment: ACE inhibitors; Diuretics; Glucophage; Liposuction 3) By Dosage: Tablet; Injection 4) By Ro

Publisher The Business Research Company
Published Sep 21, 2023
Length 175 Pages
SKU # BRC18193059

Description

Cardiometabolic Diseases Global Market Report 2023

Including: 1) By Type: Chronic/Congestive Heart Failure; Hypertension; Type 2 Diabetes; Obesity2) By Treatment: ACE inhibitors; Diuretics; Glucophage; Liposuction3) By Dosage: Tablet; Injection4) By Route Of Administration: Oral; Intravenous5) By End-Users: Clinic; HospitalCovering: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co Inc.; AbbVie Inc.


Cardiometabolic Diseases Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiometabolic diseases market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for cardiometabolic diseases? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiometabolic diseases market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Type: Chronic/Congestive Heart Failure; Hypertension; Type 2 Diabetes; Obesity

2) By Treatment: ACE inhibitors; Diuretics; Glucophage; Liposuction; Other Treatments

3) By Dosage: Tablet; Injection

4) By Route Of Administration: Oral; Intravenous; Other Routes Of Administration

5) By End-Users: Clinic; Hospital; Other End-Users

Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co Inc.; AbbVie Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Cardiometabolic Diseases Market Characteristics
3. Cardiometabolic Diseases Market Trends And Strategies
4. Cardiometabolic Diseases Market - Macro Economic Scenario
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Cardiometabolic Diseases Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Cardiometabolic Diseases Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Cardiometabolic Diseases Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market
6. Cardiometabolic Diseases Market Segmentation
6.1. Global Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Chronic Or Congestive Heart Failure
Hypertension
Type 2 Diabetes
Obesity
6.2. Global Cardiometabolic Diseases Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
ACE inhibitors
Diuretics
Glucophage
Liposuction
Other Treatments
6.3. Global Cardiometabolic Diseases Market, Segmentation By Dosage, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Tablet
Injection
6.4. Global Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Oral
Intravenous
Other Routes Of Administrations
6.5. Global Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Clinic
Hospital
Others End-Users
7. Cardiometabolic Diseases Market Regional And Country Analysis
7.1. Global Cardiometabolic Diseases Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Cardiometabolic Diseases Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Cardiometabolic Diseases Market
8.1. Asia-Pacific Cardiometabolic Diseases Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Cardiometabolic Diseases Market
9.1. China Cardiometabolic Diseases Market Overview
9.2. China Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Cardiometabolic Diseases Market
10.1. India Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Cardiometabolic Diseases Market
11.1. Japan Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Cardiometabolic Diseases Market
12.1. Australia Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Cardiometabolic Diseases Market
13.1. Indonesia Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Cardiometabolic Diseases Market
14.1. South Korea Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Cardiometabolic Diseases Market
15.1. Western Europe Cardiometabolic Diseases Market Overview
15.2. Western Europe Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Cardiometabolic Diseases Market
16.1. UK Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Cardiometabolic Diseases Market
17.1. Germany Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Cardiometabolic Diseases Market
18.1. France Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Italy Cardiometabolic Diseases Market
19.1. Italy Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Spain Cardiometabolic Diseases Market
20.1. Spain Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. Eastern Europe Cardiometabolic Diseases Market
21.1. Eastern Europe Cardiometabolic Diseases Market Overview
21.2. Eastern Europe Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. Russia Cardiometabolic Diseases Market
22.1. Russia Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. North America Cardiometabolic Diseases Market
23.1. North America Cardiometabolic Diseases Market Overview
23.2. North America Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. USA Cardiometabolic Diseases Market
24.1. USA Cardiometabolic Diseases Market Overview
24.2. USA Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Canada Cardiometabolic Diseases Market
25.1. Canada Cardiometabolic Diseases Market Overview
25.2. Canada Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. South America Cardiometabolic Diseases Market
26.1. South America Cardiometabolic Diseases Market Overview
26.2. South America Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Brazil Cardiometabolic Diseases Market
27.1. Brazil Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28. Middle East Cardiometabolic Diseases Market
28.1. Middle East Cardiometabolic Diseases Market Overview
28.2. Middle East Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29. Africa Cardiometabolic Diseases Market
29.1. Africa Cardiometabolic Diseases Market Overview
29.2. Africa Cardiometabolic Diseases Market, Segmentation By Type , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Cardiometabolic Diseases Market, Segmentation By Routes Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Cardiometabolic Diseases Market, Segmentation By End-Users , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
30. Cardiometabolic Diseases Market Competitive Landscape And Company Profiles
30.1. Cardiometabolic Diseases Market Competitive Landscape
30.2. Cardiometabolic Diseases Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson & Johnson
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. F. Hoffmann-La Roche AG
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Merck & Co Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. AbbVie Inc.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Cardiometabolic Diseases Market Other Major And Innovative Companies
31.1. Bayer AG
31.2. Novartis AG
31.3. Sanofi SA
31.4. Kowa Company Ltd.
31.5. Thermo Fisher Scientific
31.6. Abbott Laboratories
31.7. Takeda Pharmaceutical Company
31.8. Eli Lilly and Company
31.9. Novo Nordisk A/S
31.10. Siemens Healthineers
31.11. Boehringer Ingelheim International GmbH
31.12. Becton, Dickinson and Company
31.13. Stryker Corporation
31.14. AstraZeneca Plc
31.15. Viatris Inc.
32. Global Cardiometabolic Diseases Market Competitive Benchmarking
33. Global Cardiometabolic Diseases Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Cardiometabolic Diseases Market
35. Cardiometabolic Diseases Market Future Outlook and Potential Analysis
35.1 Cardiometabolic Diseases Market In 2027 - Countries Offering Most New Opportunities
35.2 Cardiometabolic Diseases Market In 2027 - Segments Offering Most New Opportunities
35.3 Cardiometabolic Diseases Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us